Literature DB >> 10483847

Cannabis use in psychotic patients.

S Sembhi1, J W Lee.   

Abstract

OBJECTIVE: The purpose of this study was to examine the level of cannabis use in psychotic patients admitted to two acute admission wards in New Zealand. Symptomatology was investigated using the Brief Psychiatric Rating Scale (BPRS).
METHOD: During a 1 -month period, all acute admissions to Tokanui Hospital with psychosis were interviewed and symptoms rated on the BPRS (n = 35). Cannabis use was recorded with a questionnaire and urine test. Those positive for cannabis were compared to those negative.
RESULTS: Thirty patients (86%) had tried cannabis at least once and 11 (31%) were positive on urine screen. Those with positive urine tests were significantly more likely to use cannabis most days (p < 0.001). This positive urine test group was less likely to be thought disordered, suspicious or deluded (as measured by the BPRS).
CONCLUSIONS: Cannabis use was widespread in this sample of patients with psychosis and may affect their symptomatology. Larger studies are needed to examine these associations in more detail.

Entities:  

Mesh:

Year:  1999        PMID: 10483847     DOI: 10.1080/j.1440-1614.1999.00588.x

Source DB:  PubMed          Journal:  Aust N Z J Psychiatry        ISSN: 0004-8674            Impact factor:   5.744


  3 in total

1.  Meta-analysis of self-reported substance use compared with laboratory substance assay in general adult mental health settings.

Authors:  Matthew M Large; Glen Smith; Grant Sara; Michael B Paton; Karina Karolina Kedzior; Olav B Nielssen
Journal:  Int J Methods Psychiatr Res       Date:  2012-02-27       Impact factor: 4.035

2.  Psychosocial Interventions in Reducing Cannabis Use in Early Phase Psychosis: A Canadian Survey of Treatments Offered.

Authors:  Cristina Aydin; Philip G Tibbo; Zenovia Ursuliak
Journal:  Can J Psychiatry       Date:  2016-03-16       Impact factor: 4.356

3.  Clinical presentations of substance abuse in bipolar heroin addicts at time of treatment entry.

Authors:  Icro Maremmani; Angelo Giovanni Icro Maremmani; Fabio Rugani; Luca Rovai; Matteo Pacini; Silvia Bacciardi; Joseph Deltito; Liliana Dell'osso; Hagop S Akiskal
Journal:  Ann Gen Psychiatry       Date:  2012-09-03       Impact factor: 3.455

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.